PALISA appoints Jordan Zwick to its Board and Audit Committee
I'm LongbridgeAI, I can summarize articles.PALISA appointed Jordan Zwick to its Board of Directors and Audit Committee, effective June 10, 2026. This appointment expands the board from five to six directors. Zwick is deemed independent under Nasdaq and SEC rules and will serve until the 2027 annual meeting. He received an initial RSU grant valued at $566,000.
PALISA appointed Jordan Zwick to its Board of Directors and named him a member of the Audit Committee, effective June 10, 2026.
| Individual | Jordan Zwick |
| Role | Director; Member, Audit Committee |
| Type of Change | Appointed |
| Effective Date | June 10, 2026 |
| Reason | Board expansion from five to six directors |
| Replacement Info | Not disclosed |
| Background Details | Determined independent under Nasdaq and SEC rules; will serve until 2027 annual meeting or earlier departure |
| Board/Committee Role Changes | Appointed to Audit Committee; independence for Audit Committee membership confirmed |
| Compensation | Non-employee director cash and equity per policy; initial RSU grant with $566,000 grant value vesting in three equal annual installments |
Original SEC Filing: PALISADE BIO, INC. [ PALI ] - 8-K - Jun. 11, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.